Form 8-K INTEGRA LIFESCIENCES For: May 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Oppenheimer Downgrades Integra LifeSciences (IART) to Perform
May 7, 2024 6:09 AM EDTOppenheimer analyst Steven Lichtman downgraded Integra LifeSciences (NASDAQ: IART) from Outperform to Perform.
The analyst comments "Following an announced delay in manufacturing restart at IART's Boston facility, we are downgrading IART shares from Outperform to Perform and removing our $51 price target. As a... More
Integra LifeSciences (IART) PT Lowered to $26 at BofA Securities
May 7, 2024 5:38 AM EDTBofA Securities analyst Craig Bijou lowered the price target on Integra LifeSciences (NASDAQ: IART) to $26.00 (from $42.00) while maintaining a Underperform rating.
The analyst comments "The new findings from the Boston facility audit are the latest in a series of setbacks... More
